Biofrontera Inc. Property, Plant and Equipment, Gross
Biofrontera Inc. (BFRI) had Property, Plant and Equipment, Gross of $2.41 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-13
- 2026-06-30: Property, Plant and Equipment, Gross $2.41M.
- 2026-03-31: Property, Plant and Equipment, Gross $2.45M.
- 2025-12-31: Property, Plant and Equipment, Gross $2.42M.
- 2024-12-31: Property, Plant and Equipment, Gross $693.00K.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $2.41M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.45M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $2.42M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $693.00K 10-K · filed 2026-03-19 | |
| 2023-12-31 | $691.00K 10-K · filed 2024-03-15 | |
| 2023-03-31 | $725.00K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $711.00K 10-K · filed 2024-03-15 | $710.00K 10-K · filed 2023-03-13 |
| 2022-09-30 | $709.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $708.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $677.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $673.00K 8-K · filed 2023-10-03 | |
| 2021-09-30 | $668.00K 10-Q · filed 2021-11-30 | |
| 2020-12-31 | $661.00K 10-K · filed 2022-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |